Literature DB >> 3263392

Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.

S L Bursten1, R M Locksley, J L Ryan, D H Lovett.   

Abstract

Acylation of cellular proteins with the fatty acids myristate or palmitate represents an important mechanism for the co- or posttranslational modification of proteins. Lipid A, the biologically active component of bacterial endotoxin, exerts a number of biochemical effects on responsive cell types. Evidence is presented that lipid A stimulates the synthesis and subsequent myristyl acylation of intracellular monocyte and glomerular mesangial cell proteins. Two of the myristylated monocyte proteins were identified by specific immunoprecipitation as the 33-kD IL 1 alpha and beta precursors; a similar myristylated protein was found in mesangial cells. The 17-kD secretory form of monocyte IL 1 beta did not contain covalently linked myristate. Myristyl acylation of the IL 1 precursor proteins may facilitate the processing or membrane localization of these proteins, which lack characteristic hydrophobic signal sequences. The acylated 33-kD IL 1 alpha may remain preferentially associated with the membrane in an active form, whereas limited proteolysis may convert the biologically inactive IL 1 beta precursor into the extracellular, nonacylated, active 17-kD protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263392      PMCID: PMC442712          DOI: 10.1172/JCI113755

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Two-dimensional electrophoresis of small-molecular-weight proteins.

Authors:  M R Goldsmith; E C Rattner; M M Koehler; S R Balikov; S C Bock
Journal:  Anal Biochem       Date:  1979-10-15       Impact factor: 3.365

4.  Stimulation of rat mesangial cell proliferation by macrophage interleukin 1.

Authors:  D H Lovett; J L Ryan; R B Sterzel
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

5.  n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle.

Authors:  S A Carr; K Biemann; S Shoji; D C Parmelee; K Titani
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.

Authors:  D H Lovett; A Larsen
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid.

Authors:  B M Sefton; I S Trowbridge; J A Cooper; E M Scolnick
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

8.  Neutral proteinase activity produced in vitro by cells of the glomerular mesangium.

Authors:  D H Lovett; R B Sterzel; M Kashgarian; J L Ryan
Journal:  Kidney Int       Date:  1983-02       Impact factor: 10.612

9.  Covalent binding of fatty acid to the transferrin receptor in cultured human cells.

Authors:  M B Omary; I S Trowbridge
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

10.  Fatty acid acylation of eucaryotic cell membrane proteins.

Authors:  A I Magee; M J Schlesinger
Journal:  Biochim Biophys Acta       Date:  1982-11-30
View more
  13 in total

1.  Mesangial cell activation by bacterial endotoxin. Induction of rapid cytoskeletal reorganization and gene expression.

Authors:  S L Bursten; F Stevenson; F Torrano; D H Lovett
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

Review 2.  Genetic basis of multidrug resistance of tumor cells.

Authors:  S E Kane; I Pastan; M M Gottesman
Journal:  J Bioenerg Biomembr       Date:  1990-08       Impact factor: 2.945

3.  The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein.

Authors:  F T Stevenson; J Turck; R M Locksley; D H Lovett
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha.

Authors:  Y Kobayashi; K Yamamoto; T Saido; H Kawasaki; J J Oppenheim; K Matsushima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Interleukin-1 gene expression in rabbit vascular tissue in vivo.

Authors:  S K Clinton; J C Fleet; H Loppnow; R N Salomon; B D Clark; J G Cannon; A R Shaw; C A Dinarello; P Libby
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

6.  Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues.

Authors:  F T Stevenson; S L Bursten; R M Locksley; D H Lovett
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

7.  Lipid A stimulates phospholipase D activity in rat mesangial cells via a G-protein.

Authors:  W E Harrris; S L Bursten
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

8.  The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece.

Authors:  F T Stevenson; S L Bursten; C Fanton; R M Locksley; D H Lovett
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

9.  Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes.

Authors:  H Mizutani; R Black; T S Kupper
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Interleukin 1 beta propeptide is detected intracellularly and extracellularly when human monocytes are stimulated with LPS in vitro.

Authors:  G C Higgins; J L Foster; A E Postlethwaite
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.